The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections
Abstract
Daptomycin is the first available agent from a new class of antibiotics, the cyclic lipopeptides, that has activity against a broad range of gram-positive pathogens, including organisms that are resistant to methicillin, vancomycin, and other currently available agents. Daptomycin (4 mg/kg intraveno …
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
treatment outcome
adult
female
male
aged
middle aged
Skin Diseases
Comparative Study
Clinical Trial
Phase III
Randomized Controlled Trial
Multicenter Study
anti-bacterial agents / adverse effects
penicillins / therapeutic use
anti-bacterial agents / administration & dosage
anti-bacterial agents / therapeutic use*
vancomycin / therapeutic use
intravenous
soft tissue infections / drug therapy*
infectious / drug therapy*
infusions
pmid:15227611
doi:10.1086/420818
robert d arbeit
dennis maki
daptomycin 98-01 and 99-01 investigators
daptomycin / administration & dosage
daptomycin / adverse effects
daptomycin / therapeutic use*
Access
Citation
ID:
114929
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
114929
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet